Safety and tolerability of ciclesonide and formoterol fumarate inhaled once daily in patients with asthma (18 to 75 y) (BY9010/M1-506)

Study identifier:BY9010/M1-506

ClinicalTrials.gov identifier:NCT00314509

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

ADVICE: A dose range finding study of formoterol administered once daily in the evening in combination with ciclesonide using the Ultrahaler™ versus monotherapy of each drug in asthmatic patients

Medical condition

asthma

Phase

Phase 2

Healthy volunteers

No

Study drug

Ciclesonide/Formoterol Combination

Sex

All

Actual Enrollment

240

Study type

Interventional

Age

18 Years - 75 Years

Date

Study Start Date: 01 Jul 2005
Primary Completion Date: 01 Jan 2006
Study Completion Date: 01 Jan 2006

Study design

Allocation: Randomized
Endpoint Classification: None
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Dec 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria